671 related articles for article (PubMed ID: 20211139)
1. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
[TBL] [Abstract][Full Text] [Related]
2. TRIAD3/RNF216 mutations associated with Gordon Holmes syndrome lead to synaptic and cognitive impairments via Arc misregulation.
Husain N; Yuan Q; Yen YC; Pletnikova O; Sally DQ; Worley P; Bichler Z; Shawn Je H
Aging Cell; 2017 Apr; 16(2):281-292. PubMed ID: 27995769
[TBL] [Abstract][Full Text] [Related]
3. [From pathogenesis to treatment of genetic intellectual disabilities: a lesson from Angelman syndrome research].
Saitoh S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):127-30. PubMed ID: 25069246
[TBL] [Abstract][Full Text] [Related]
4. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.
Kühnle S; Mothes B; Matentzoglu K; Scheffner M
Proc Natl Acad Sci U S A; 2013 May; 110(22):8888-93. PubMed ID: 23671107
[TBL] [Abstract][Full Text] [Related]
5. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
Sun J; Liu Y; Zhu G; Cato C; Hao X; Qian L; Lin W; Adhikari R; Luo Y; Baudry M; Bi X
Sci Rep; 2020 Jun; 10(1):9824. PubMed ID: 32555345
[TBL] [Abstract][Full Text] [Related]
6. Modulation of hippocampal synapse maturation by activity-regulated E3 ligase via non-canonical pathway.
Kumari P; Srinivasan B; Banerjee S
Neuroscience; 2017 Nov; 364():226-241. PubMed ID: 28890050
[TBL] [Abstract][Full Text] [Related]
7. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
Maheshwari M; Samanta A; Godavarthi SK; Mukherjee R; Jana NR
J Biol Chem; 2012 Aug; 287(35):29949-57. PubMed ID: 22787151
[TBL] [Abstract][Full Text] [Related]
9. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
[TBL] [Abstract][Full Text] [Related]
10. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation.
Margolis SS; Salogiannis J; Lipton DM; Mandel-Brehm C; Wills ZP; Mardinly AR; Hu L; Greer PL; Bikoff JB; Ho HY; Soskis MJ; Sahin M; Greenberg ME
Cell; 2010 Oct; 143(3):442-55. PubMed ID: 21029865
[TBL] [Abstract][Full Text] [Related]
11. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
12. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
14. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
15. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
16. Arc ubiquitination in synaptic plasticity.
Mabb AM; Ehlers MD
Semin Cell Dev Biol; 2018 May; 77():10-16. PubMed ID: 28890418
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic approaches for Angelman syndrome.
Bi X; Sun J; Ji AX; Baudry M
Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
[TBL] [Abstract][Full Text] [Related]
18. Angelman syndrome at the synapse: meeting report of the Angelman Syndrome Foundation's 2009 scientific symposium.
Williams C; Franco L
J Child Neurol; 2010 Feb; 25(2):254-61. PubMed ID: 20101047
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
[TBL] [Abstract][Full Text] [Related]
20. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
